UNSPSC 51172904: Cystine/inositol/methionine/sodium propionate/urea

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GU900. This VA Drug Class (GU900) classifies this compound as belonging to the group GENITO-URINARY AGENTS, OTHER.

UNSPSC 51172904 Cystine/inositol/methionine/sodium propionate/urea (Commodity) shows minimal recent activity aligned with its nominal scope. The two posted opportunities under this code in the past six months involve sodium bisulfite for water treatment and generic pharmaceuticals for cooperative purchasing — neither matches the code's stated commodity line. State and local procurement offices tagging these opportunities with this code suggests a misalignment between how the code is being applied and its intended product scope.

The City of Meriden (Connecticut) issued IFB B027-15 on July 8, 2026, for sodium bisulfite chemical supply for its Water Pollution Control Facility, with bids due July 29, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, with proposals due March 26, 2026. Neither pharmaceutical nor water-treatment chemicals align with the code's stated components. The code shows limited recent procurement activity under its actual scope among state and local governments.